Previous studies have confirmed that the expression of TLR2 in left atrial blood samples of AF patients is significantly increased and that TLR2 has the potential to be a new biomarker for new-onset AF after acute myocardial infarction (35, 36). Here, TLR2 is linked to atrial fibrillation.